ANI Pharmaceuticals(us:ANIP)
54.13
+1.46%
Updated on 2024-12-23
Open:53.39
Close:54.13
High:54.33
Low:52.79
Pre Close:53.35
Volume:77920.00
Amount:4.17M
Turnover:0.37%
Shares:21.07M
MarketCap:1.14B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 226 | 15102863 | 71.66% | 32 | 74 | 89 |
| 2024-03-31 | 219 | 14094995 | 67.15% | 40 | 66 | 76 |
| 2023-12-31 | 214 | 13594350 | 66.39% | 31 | 55 | 87 |
| 2023-09-30 | 199 | 13188483 | 64.63% | 30 | 71 | 66 |
| 2023-06-30 | 180 | 12284416 | 60.52% | 43 | 71 | 39 |
| 2023-03-31 | 146 | 10469818 | 58.16% | 25 | 33 | 61 |
| 2022-12-31 | 142 | 10249360 | 58.55% | 19 | 46 | 50 |
| 2022-09-30 | 132 | 9835279 | 56.27% | 17 | 32 | 60 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 2656515 | 12.61% | 125172 | 4.95% |
| 2024-06-30 | Vanguard Group Inc | 1440444 | 6.83% | 134012 | 10.26% |
| 2024-06-30 | State Street Corp | 645145 | 3.06% | 70307 | 12.23% |
| 2024-06-30 | Dimensional Fund Advisors Lp | 630226 | 2.99% | 21053 | 3.46% |
| 2024-06-30 | Rubric Capital Management Lp | 603800 | 2.87% | -354733 | -37.01% |
| 2024-06-30 | Global Alpha Capital Management Ltd. | 526950 | 2.50% | 136200 | 34.86% |
| 2024-06-30 | William Blair Investment Management, Llc | 489386 | 2.32% | -879 | -0.18% |
| 2024-06-30 | Deep Track Capital, Lp | 466089 | 2.21% | -355912 | -43.30% |
| 2024-06-30 | Tang Capital Management Llc | 450000 | 2.14% | 300000 | 200.00% |
| 2024-06-30 | Geode Capital Management, Llc | 407911 | 1.94% | 68547 | 20.20% |
About
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Address:210 Main Street West
Market Movers